carbachol has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vermeiren, C | 1 |
| Hemptinne, I | 1 |
| Vanhoutte, N | 1 |
| Tilleux, S | 1 |
| Maloteaux, JM | 1 |
| Hermans, E | 1 |
1 other study available for carbachol and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Aspartic Acid; Astrocytes; Bl | 2006 |